ECM hydrogels are injectable biomaterials created from decellularized extracellular matrix.
When processed into hydrogel form, our material retains native ECM components that are conducive to constructive tissue remodeling.
Today, ECM-based materials are widely used in wound care, reconstructive surgery, and soft tissue repair, where they act as a biologic scaffold that supports cell attachment, recruits the body's own repair cells, and helps guide the formation of new, functional tissue.
Matrix bound nanovesicles (MBV) are naturally occurring vesicles embedded within the extracellular matrix.
Unlike free-circulating exosomes, MBV remain sequestered within the matrix and are released during matrix remodeling.
Carrying bioactive cargo, MBV are biologics that modulate the immune response, influence cellular differentiation, and support tissue repair pathways. Their nanometer-scale size enables precise delivery of a potent ECM signaling package into confined spaces, irregular geometries, and delicate wound sites such as the cornea.
Extensive preclinical studies, peer-reviewed publications, and clinical experience with ECM-based materials provide our foundation.
Capella-Monsonís et al.
Crum et al.
Crum et al.
Turner et al.
Cramer et al.
Crum et al.
Crum et al.
Murdock et al.
Modo et al.
Saldin et al.
Ghuman et al.
Quijano et al.
Li et al.
Naranjo et al.
Hussey et al.
van der Merwe et al.
Hussey et al.
Pineda Molina et al.
Ghuman et al.
Murdock et al.
Murdock et al.
Saldin et al.
Hussey et al.
Keane et al.
Dziki et al.
Huleihel et al.
Keane et al.
Badylak et al.